←Back to Expert Scholars
Translational Medicine / 转化医学Cutaneous T-Cell Lymphoma
Madeleine Duvic
MD
🏢MD Anderson Cancer Center🌐USA
Professor Emeritus of Dermatology
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Madeleine Duvic led the landmark vorinostat trial establishing HDAC inhibitor therapy for CTCL. Her pioneering work has shaped CTCL treatment options over multiple decades. She remains a global authority in cutaneous lymphoma clinical research.
Share:
🧪Research Fields 研究领域
CTCL
Vorinostat
HDAC inhibitors
Clinical trials
Mycosis fungoides
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Madeleine Duvic 的研究动态
Follow Madeleine Duvic's research updates
留下邮箱，当我们发布与 Madeleine Duvic（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment